Last $0.64 USD
Change Today +0.09 / 16.36%
Volume 26.7K
ORGS On Other Exchanges
As of 1:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

orgenesis inc (ORGS) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/28/14 - $1.00
52 Week Low
06/24/14 - $0.34
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ORGENESIS INC (ORGS)

Related News

No related news articles were found.

orgenesis inc (ORGS) Related Businessweek News

No Related Businessweek News Found

orgenesis inc (ORGS) Details

Orgenesis Inc., a development stage company, is engaged in research and development in the biotechnology field in Israel. It intends to develop a technology for regeneration of functional insulin-producing cells thus enabling normal glucose regulated insulin secretion through cell therapy. The company was formerly known as Business Outsourcing Services, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was founded in 2008 and is based in White Plains, New York.

2 Employees
Last Reported Date: 08/1/14
Founded in 2008

orgenesis inc (ORGS) Top Compensated Officers

Founder and Chief Scientific Officer
Total Annual Compensation: $200.6K
Total Annual Compensation: $126.6K
Compensation as of Fiscal Year 2013.

orgenesis inc (ORGS) Key Developments

Orgenesis Inc. Presents at 2nd Global Life Sciences Conference, Oct-02-2014 03:00 PM

Orgenesis Inc. Presents at 2nd Global Life Sciences Conference, Oct-02-2014 03:00 PM. Venue: Warsaw Stock Exchange, Trading Floor, Ksiazeca 4, Warsaw, Poland. Speakers: Scott Carmer, Chief Executive Officer of North America, Vered Caplan, Chairperson, Chief Executive Officer, President, Member of Audit Committee and Member of Compensation Committee.

Orgenesis Inc. Confirms Vered Caplan as President and Chief Executive Officer

On August 14, 2014, the Board of Directors of Orgenesis Inc. has confirmed that Ms. Vered Caplan, who has served as President and Chief Executive Officer on an interim basis since December 23, 2013, has been appointed as President and Chief Executive Officer.

Orgenesis Inc. Announces Executive Changes

Effective August 1, 2014, Joseph Tenne resigned as Chief Financial Officer, Treasurer and Secretary of Orgenesis Inc. Mr. Tenne's resignation was not as a result of any disagreement with company operations, policies or practices but for personal reasons. Mr. Tenne will remain as Chief Financial Officer of Israeli subsidiary, Orgenesis Ltd. On August 1, 2014, the company appointed Neil Reithinger as Chief Financial Officer, treasurer and Secretary pursuant to an employment agreement. Neil Reithinger is the Founder and President of Eventus Advisory Group, LLC. He is also the President of Eventus Consulting, P.C.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORGS:US $0.64 USD +0.09

ORGS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ORGS.
View Industry Companies

Industry Analysis


Industry Average

Valuation ORGS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORGENESIS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at